La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Mayinglong Pharmaceutical Group Gestione
Gestione criteri di controllo 2/4
We currently do not have sufficient information about the CEO.
Informazioni chiave
Youzhang Xia
Amministratore delegato
CN¥1.8m
Compenso totale
Percentuale dello stipendio del CEO | n/a |
Mandato del CEO | no data |
Proprietà del CEO | n/a |
Durata media del management | Nessun dato |
Durata media del Consiglio di amministrazione | Nessun dato |
Aggiornamenti recenti sulla gestione
Recent updates
What Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) P/E Is Not Telling You
Aug 19Mayinglong Pharmaceutical Group's (SHSE:600993) Shareholders Will Receive A Bigger Dividend Than Last Year
Jul 24Mayinglong Pharmaceutical Group (SHSE:600993) Has A Rock Solid Balance Sheet
Jun 19Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) Price Is Right But Growth Is Lacking After Shares Rocket 26%
May 07Investors Don't See Light At End Of Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) Tunnel
Mar 22AMMINISTRATORE DELEGATO
Youzhang Xia (45 yo)
no data
Mandato
CN¥1,800,000
Compensazione
Mr. Youzhang Xia serves as General Manager and Director at Mayinglong Pharmaceutical Group Co., Ltd. and served as its Deputy General Manager and Secretary of the Board.